Ameris Bancorp vs Hilltop
ABCB and HTH side by side, both in commercial banks. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ABCB and HTH compare
Ameris Bancorp is the larger company, worth 2.7 times as much as Hilltop ($5.6B against $2.0B).
On earnings, Hilltop is cheaper: it trades at 14.9× trailing earnings, against 15.0× for Ameris Bancorp.
Ameris Bancorp grew revenue faster over the last twelve months (8.7% versus 0.21% for Hilltop).
Ameris Bancorp keeps more of each dollar of sales as profit, with a net margin of 29.8% compared with 11.2% at Hilltop.
Both pay dividends: Ameris Bancorp yields 0.97% and Hilltop 1.7%.
Hilltop scores higher on the StockData Score (12 against 11 for Ameris Bancorp), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ABCB | HTH |
|---|---|---|
| Size and price | ||
| Market cap | $5.6B | $2.0B |
| Share price | $82.71 | $35.78 |
| Change, 1 year | 14.1% | 6.9% |
| Change, 5 years | 65.2% | 2.7% |
| Beta (5Y) | 0.45 | 0.21 |
| Employees | 616 | 3,500 |
| StockData Score | ||
| Total score | 11 | 12 (better) |
| Valuation score | 0 | 4 (better) |
| Growth score | 0 | 1 (better) |
| Performance score | 2 (better) | 0 |
| Health score | 5 (better) | 3 |
| Dividend score | 4 | 4 |
| Valuation | ||
| P/E | 15.0× | 14.9× (better) |
| P/S | 4.4× | 1.6× (better) |
| P/B | 1.4× | 1.0× (better) |
| P/FCF | 10.6× (better) | 18.5× |
| PEG | 2.36 | 0.82 (better) |
| FCF yield | 9.4% (better) | 5.4% |
| Fair value | $69.62 | $37.26 |
| Margin of safety | −18.8% | 4.0% (better) |
| Growth | ||
| Revenue growth (TTM) | 8.7% (better) | 0.21% |
| Revenue growth, 5Y average | 2.2% (better) | −9.5% |
| Net income growth (TTM) | −3.8% (better) | −11.7% |
| EPS growth (TTM) | −2.5% (better) | −4.4% |
| EPS growth, 5Y average | 9.7% (better) | −12.0% |
| Profitability | ||
| Net margin | 29.8% (better) | 11.2% |
| FCF margin | 41.4% (better) | 8.8% |
| Return on equity | 9.4% (better) | 6.6% |
| Financial health | ||
| Debt / equity | – | 0.39 |
| Altman Z-score | 0.30 (better) | 0.27 |
| Piotroski F-score | 6 (better) | 5 |
| Dividends and buybacks | ||
| Dividend yield | 0.97% | 1.7% (better) |
| Payout ratio | 14.6% | 33.4% |
| Years of dividend growth | 2 | 9 (better) |
| Dividend growth, 5Y average | 5.9% | 14.9% (better) |
| Buyback yield | 2.7% | 8.6% (better) |
| Shareholder yield | 3.7% | 10.4% (better) |
| Ownership | ||
| Held by institutions | 100.0% | 56.3% |
| Held by insiders | 5.8% | 61.0% |
| Insider net buying, 12 months | −$542K (better) | −$15.3M |
| Short interest, % of float | 4.0% | 9.6% |
Go deeper
- ABCB stock overview
- ABCB income statement
- ABCB valuation and score
- HTH stock overview
- HTH income statement
- HTH valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.